Special Drug Use Investigation for LAMICTAL Bipolar
Phase of Trial: Phase IV
Latest Information Update: 15 Aug 2017
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 15 Aug 2017 Primary endpoint (Time to recurrence/relapse of mood episodes in patients) has been met, as per results published in the Journal of Clinical Psychiatry.
- 15 Aug 2017 Results (n=966) published in the Journal of Clinical Psychiatry.
- 21 Apr 2016 Status changed from not yet recruiting to completed.